Skip to main content
. Author manuscript; available in PMC: 2019 Jan 15.
Published in final edited form as: J Neuroimmunol. 2017 Oct 18;314:17–23. doi: 10.1016/j.jneuroim.2017.10.005

Table 1.

Demographic and clinical characteristics of study participants (n=22) as well as descriptive statistics of cytokine and receptor concentrations.

Characteristic N (%)
Age (mean (S.D.)) 54.36 (12.15)

Ethnicity
 Caucasian 21 (95.5)
 Not Caucasian 1 (4.5)

Education1
 No high school diploma or GED 1 (4.8)
 High school diploma or GED 1 (4.8)
 2–4 year college degree 12 (57.1)
 4 year college degree 1 (4.8)
 Graduate degree 6 (28.5)

Staging
 Stage I 1 (4.6)
 Stage II 7 (31.8)
 Stage III 5 (22.7)
 Stage IV 9 (40.9)

Treatment Regiment2
 Non-anthracycline-based treatment 12 (57.1)
 Anthracycline-based treatment 9 (42.9)

Number of Previous Cycles (median (min, max)) 2 (1,6)

Cytokine concentration (median (IQR)) Median (IQR)
 MCP1 123.47 (364.11)
 TNF-α 6.43 (4.63)
 sTNFRI 1721.89 (708.83)
 sTNFRII 6815.29 (2975.38)
1

One missing value for education,

2

one missing value for treatment regimen.